Form SC 13G - Statement of acquisition of beneficial ownership by individuals
12 Octubre 2023 - 3:05PM
Edgar (US Regulatory)
United States
Securities and Exchange Commission
Washington, D.C. 20549
Schedule 13G
(Rule 13d-102)
Information to be Included in Statements Filed Pursuant
to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed
Pursuant to § 240.13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. )*
FREQUENCY
THERAPEUTICS, INC.
(Name of Issuer)
Common Stock
(Title of
Class of Securities)
35803L108
(CUSIP Number)
December 31, 2022
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to
designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☐ Rule 13d-1(c)
☒
Rule 13d-1(d)
* |
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form
with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities
Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
|
|
|
|
CUSIP No. 35803L108 |
|
Schedule 13G |
|
Page 1 of 4 |
|
|
|
|
|
|
|
1 |
|
Names of Reporting Persons
David L. Lucchino |
2 |
|
Check the Appropriate Box if a
Member of a Group
(a) ☐ (b) ☐ |
3 |
|
SEC Use Only
|
4 |
|
Citizenship or Place of
Organization United
States |
|
|
|
|
|
|
|
Number of
Shares Beneficially
Owned by Each
Reporting Person
With |
|
5 |
|
Sole Voting Power
2,368,527 |
|
6 |
|
Shared Voting Power
0 |
|
7 |
|
Sole Dispositive Power
2,368,527 |
|
8 |
|
Shared Dispositive Power
0 |
|
|
|
|
|
|
|
9 |
|
Aggregate Amount Beneficially Owned by Each Reporting Person
2,368,527 |
10 |
|
Check if the Aggregate Amount
in Row (9) Excludes Certain Shares Not Applicable |
11 |
|
Percent of Class Represented by
Amount in Row 9 6.2% |
12 |
|
Type of Reporting Person
IN |
|
|
|
|
|
CUSIP No. 35803L108 |
|
Schedule 13G |
|
Page 2 of 4 |
ITEM 1. (a) |
Name of Issuer: |
Frequency Therapeutics, Inc. (the Issuer).
|
(b) |
Address of Issuers Principal Executive Offices: |
75 Hayden Avenue, Suite 300, Lexington, MA 02421.
ITEM 2. (a) |
Name of Person Filing: |
This statement is filed on behalf of David L. Lucchino (the Reporting Person).
|
(b) |
Address or Principal Business Office: |
The business address of the Reporting Person is c/o Frequency Therapeutics, Inc., 75 Hayden Avenue, Suite 300, Lexington, MA 02421.
The Reporting Person is a citizen of the United States.
|
(d) |
Title of Class of Securities: |
Common stock, par value $0.001 per share (Common Stock).
35803L108
Not applicable.
ITEM 4. Ownership.
The ownership information below represents beneficial ownership of shares of Common Stock as of the date hereof, based upon 36,520,750
shares of Common Stock outstanding as of August 1, 2023, as disclosed in the Issuers Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 10, 2023.
|
(a) |
Amount beneficially owned: |
The Reporting Person may be deemed to beneficially own 2,368,527 shares of Common Stock, which includes (i) 633,744 shares of
Common Stock and (ii) 1,734,783 shares of Common Stock underlying stock options that are exercisable or will become exercisable within 60 days of the date hereof.
|
|
|
|
|
CUSIP No. 35803L108 |
|
Schedule 13G |
|
Page 3 of 4 |
|
(b) |
Percent of class: 6.2% |
|
(c) |
Number of shares as to which the person has: |
|
(i) |
Sole power to vote or to direct the vote: 2,368,527 |
|
(ii) |
Shared power to vote or direct the vote: 0 |
|
(iii) |
Sole power to dispose or to direct the disposition of: 2,368,527 |
|
(iv) |
Shared power to dispose or to direct the disposition of: 0 |
ITEM 5. |
Ownership of Five Percent or Less of a Class. |
Not applicable.
ITEM 6. |
Ownership of More than Five Percent on Behalf of Another Person. |
Not applicable.
ITEM 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the
Parent Holding Company. |
Not applicable.
ITEM 8. |
Identification and Classification of Members of the Group. |
Not applicable.
ITEM 9. |
Notice of Dissolution of Group. |
Not applicable.
Not applicable.
|
|
|
|
|
CUSIP No. 35803L108 |
|
Schedule 13G |
|
Page 4 of 4 |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
Date: October 12, 2023
|
David L. Lucchino |
|
/s/ David L. Lucchino |
Frequency Therapeutics (NASDAQ:FREQ)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Frequency Therapeutics (NASDAQ:FREQ)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024